Effect of atenolol and labetalol on serum lipids.
Adverse alterations in lipid profile suggesting higher atherogenicity were observed following 12 weeks treatment with atenolol in patients of hypertension. No significant alterations in lipid profile were observed with labetalol therapy.
Siwach
S B
SB
Dept. of Med & Biochem, Medical College, Rohtak.
Dahiya
S S
SS
Seth
S
S
Seth
R K
RK
Sharma
D
D
D001262:Atenolol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects*; D008055:Lipids / Q000097:blood*; D008297:Male
D008055:Lipids; D001262:Atenolol; D007741:Labetalol